Autologous Chondrocyte Implantation Vs Arthroscopic Debridement For Knee Cartilage Lesions .
Autologous Chondrocyte Implantation Is Not Better Than Arthroscopic Debridement for the Treatment of Symptomatic Cartilage Lesions of the Knee: Two-Year Results From a Randomized-Controlled Trial.
Arthrosc SpoArthrosc Sports Med Rehabil . 2024 Feb 16;6(2):100909.rts Med Rehabil. 2024 01-Apr;():. 10.1016/j.asmr.2024.100909Twenty-eight patients with symptomatic isolated cartilage lesions of the knee were randomized to receive autologous chondrocyte implantation (ACI; n=15) or arthroscopic debridement (AD; n=13). The primary outcome of interest was the change in the Knee Injury and Osteoarthritis Outcome Score (KOOS) quality of life (QoL) subscale. Secondary outcomes included KOOS subscales (pain, symptoms, activities of daily living, sports/recreation), Tegner score, Lysholm score, and visual analog scale for pain. Outcomes were assessed at 3, 6, 12, and 24 months. Overall, the results of the study revealed that while both groups improved, the AD group had statistically significantly better results in several KOOS subscales, including QoL, at 2 years. This suggests that AD followed by physiotherapy may be as effective or superior to ACI for knee cartilage lesions over this time frame.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics